Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Aug 15, 2024

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Neurocrine Biosciences Inc
0
$96.60
-$1,245,716.45
—
119.05K
Aug 13
Scheduled
Neurocrine Biosciences Inc
0
$96.40
-$99,763.42
—
119.05K
Jul 16
Scheduled
Neurocrine Biosciences Inc
0
—
—
—
0
May 22
Neurocrine Biosciences Inc
2.1K
—
—
+1.80%
119.05K
May 17
Neurocrine Biosciences Inc
0
$89.20
-$1,160,870.00
—
116.95K
May 14
Scheduled
Travere Therapeutics, Inc.
6.5K
—
—
+14.61%
51K
May 8
Neurocrine Biosciences Inc
-10.00K
$130.04
-$1,300,443.00
-4.91%
193.7K
Dec 22
Scheduled
Neurocrine Biosciences Inc
0
$64.88
-$518,937.00
—
203.7K
Dec 1
Scheduled
Neurocrine Biosciences Inc
0
$64.00
-$510,220.00
—
203.7K
Sep 12
Neurocrine Biosciences Inc
0
$61.52
-$485,415.50
—
203.7K
Sep 1
Rigel Pharmaceuticals Inc
25K
—
—
+50.00%
75K
May 26
Neurocrine Biosciences Inc
0
—
—
—
0
May 17
Travere Therapeutics, Inc.
4.5K
—
—
+11.25%
44.5K
May 17
Eledon Pharmaceuticals, Inc.
0
—
—
—
0
May 1
Eledon Pharmaceuticals, Inc.
0
—
—
—
0
Feb 1
Neurocrine Biosciences Inc
0
$63.74
-$1,530,753.00
—
203.7K
Oct 31
Scheduled
Neurocrine Biosciences Inc
-5.00K
$110.54
-$552,711.00
-2.40%
203.7K
Oct 4
Scheduled
Rigel Pharmaceuticals Inc
25K
—
—
+100.00%
50K
May 20
Neurocrine Biosciences Inc
0
—
—
—
0
May 18
Brickell Biotech, Inc.
0
—
—
—
0
May 17
Travere Therapeutics, Inc.
3K
—
—
+8.11%
40K
May 11
Neurocrine Biosciences Inc
0
$49.71
-$1,291,492.50
—
208.7K
Apr 25
Scheduled
Eledon Pharmaceuticals, Inc.
0
—
—
—
0
Feb 1
Neurocrine Biosciences Inc
-5.00K
$105.06
-$525,293.50
-2.34%
208.7K
Oct 7
Scheduled
Neurocrine Biosciences Inc
-10.00K
$100.27
-$1,002,743.00
-4.47%
213.7K
Jun 10
Scheduled
Brickell Biotech, Inc.
0
—
—
—
0
Jun 14
Rigel Pharmaceuticals Inc
25K
—
—
∞
25K
May 19
Neurocrine Biosciences Inc
0
—
—
—
0
May 19
Travere Therapeutics, Inc.
3K
—
—
+8.82%
37K
May 14
Neurocrine Biosciences Inc
-2.00K
$120.02
-$240,046.56
-0.89%
223.7K
Jan 25 - Jan 26
Scheduled
Brickell Biotech, Inc.
-5.97K
$0.78
-$4,654.26
-24.13%
18.76K
Dec 31
Brickell Biotech, Inc.
11.93K
$0.81
$9,666.54
+93.27%
24.73K
Sep 15
Novus Therapeutics, Inc.
0
—
—
—
0
Sep 11
Brickell Biotech, Inc.
-8.29K
$0.94
-$8,438.38
-39.30%
12.79K
Aug 31
Brickell Biotech, Inc.
346
$0.92
-$318.32
+1.67%
21.08K
Jul 31
Brickell Biotech, Inc.
345
$1.00
-$346.00
+1.69%
20.73K
Jun 30
Brickell Biotech, Inc.
0
—
—
—
0
Feb 14
Brickell Biotech, Inc.
20.39K
$1.36
-$4,267.44
∞
20.39K
Feb 14 - Jun 3
Neurocrine Biosciences Inc
0
—
—
—
0
May 19
Retrophin, Inc.
3K
—
—
+9.68%
34K
May 15

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...

Want to view more results?

Unlock the hidden results with your Benzinga Account now. No purchase required.